These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 23884391

  • 1. Repeatability of visual function measures in age-related macular degeneration.
    Aslam T, Mahmood S, Balaskas K, Patton N, Tanawade RG, Tan SZ, Roberts SA, Parkes J, Bishop PN.
    Graefes Arch Clin Exp Ophthalmol; 2014 Feb; 252(2):201-6. PubMed ID: 23884391
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparison of outcomes after switching treatment from intravitreal bevacizumab to ranibizumab in neovascular age-related macular degeneration.
    Kent JS, Iordanous Y, Mao A, Powell AM, Kent SS, Sheidow TG.
    Can J Ophthalmol; 2012 Apr; 47(2):159-64. PubMed ID: 22560422
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Outcomes of Anti-Vascular Endothelial Growth Factor Treatment for Choroidal Neovascularization in Fellow Eyes of Previously Treated Patients With Neovascular Age-Related Macular Degeneration.
    Stem MS, Moinuddin O, Kline N, Thanos A, Rao P, Williams GA, Hassan TS.
    JAMA Ophthalmol; 2018 Jul 01; 136(7):820-823. PubMed ID: 29800991
    [Abstract] [Full Text] [Related]

  • 8. Intravitreal bevacizumab versus combined intravitreal bevacizumab and triamcinolone for neovascular age-related macular degeneration: six-month results of a randomized clinical trial.
    Ahmadieh H, Taei R, Riazi-Esfahani M, Piri N, Homayouni M, Daftarian N, Yaseri M.
    Retina; 2011 Oct 01; 31(9):1819-26. PubMed ID: 21555967
    [Abstract] [Full Text] [Related]

  • 9. Effects of retinal morphology on contrast sensitivity and reading ability in neovascular age-related macular degeneration.
    Keane PA, Patel PJ, Ouyang Y, Chen FK, Ikeji F, Walsh AC, Tufail A, Sadda SR.
    Invest Ophthalmol Vis Sci; 2010 Nov 01; 51(11):5431-7. PubMed ID: 20554607
    [Abstract] [Full Text] [Related]

  • 10. One-year outcomes of less frequent bevacizumab in age-related macular degeneration.
    Sonmez K, Sonmez PA, Ozkan SS, Atmaca LS.
    Retina; 2011 Apr 01; 31(4):645-53. PubMed ID: 21358363
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Intralesional Macular Atrophy in Anti-Vascular Endothelial Growth Factor Therapy for Age-Related Macular Degeneration in the IVAN Trial.
    Bailey C, Scott LJ, Rogers CA, Reeves BC, Hamill B, Peto T, Chakravarthy U, Harding SP, writing committee for the IVAN Study Group.
    Ophthalmology; 2019 Jan 01; 126(1):75-86. PubMed ID: 30301555
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Bevacizumab for neovascular age-related macular degeneration in China.
    Li X, Hu Y, Sun X, Zhang J, Zhang M, Neovascular Age-Related Macular Degeneration Treatment Trial Using Bevacizumab (NATTB).
    Ophthalmology; 2012 Oct 01; 119(10):2087-93. PubMed ID: 22818896
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Short-term outcomes of aflibercept for neovascular age-related macular degeneration in eyes previously treated with other vascular endothelial growth factor inhibitors.
    Ho VY, Yeh S, Olsen TW, Bergstrom CS, Yan J, Cribbs BE, Hubbard GB.
    Am J Ophthalmol; 2013 Jul 01; 156(1):23-28.e2. PubMed ID: 23664153
    [Abstract] [Full Text] [Related]

  • 18. Therapeutic interventions for macular diseases show characteristic effects on near and distance visual function.
    Munk M, Kiss C, Huf W, Sulzbacher F, Bolz M, Sayegh R, Eisenkölbl S, Simader C, Schmidt-Erfurth U.
    Retina; 2013 Oct 01; 33(9):1915-22. PubMed ID: 23584693
    [Abstract] [Full Text] [Related]

  • 19. Intersession repeatability of visual acuity scores in age-related macular degeneration.
    Patel PJ, Chen FK, Rubin GS, Tufail A.
    Invest Ophthalmol Vis Sci; 2008 Oct 01; 49(10):4347-52. PubMed ID: 18566455
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.